XML 96 R81.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION (Summary of Reportable Segments) (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2018
USD ($)
segment
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Financial information regarding the Company's reportable segments                      
Number of reportable segments | segment                 3    
Net sales $ 685,028 $ 665,775 $ 710,608 $ 703,350 $ 625,895 $ 624,326 $ 617,746 $ 601,316 $ 2,764,761 $ 2,469,283 $ 2,330,934
Acquisition related costs                 23,770   8,217
Total Restructuring Initiatives                 63,829 2,208  
Gain on insurance recovery                   10,648  
Depreciation and amortization                 171,747 153,094 154,802
Interest expense                 (32,626) (40,597) (35,237)
Interest income                 7,056 5,470 2,643
Income before Income Taxes                 266,020 294,825 280,497
Capital Expenditures                 211,252 156,624 128,986
Total Assets 3,377,735       3,137,823       3,377,735 3,137,823 2,606,785
Business Transformation                      
Financial information regarding the Company's reportable segments                      
Total Restructuring Initiatives                 63,829 2,208  
Business Transformation | Employee severance                      
Financial information regarding the Company's reportable segments                      
Total Restructuring Initiatives                 5,107    
Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net sales                 1,426,382 1,313,786 1,261,086
Adjusted EBITDA                 185,926 173,227 186,993
Total Restructuring Initiatives                 52,244 529  
Depreciation and amortization                 83,546 79,422 84,273
Capital Expenditures                 101,371 76,425 75,165
Total Assets 1,373,816       1,358,283       1,373,816 1,358,283 1,270,858
Pharma                      
Financial information regarding the Company's reportable segments                      
Net sales                 954,652 805,880 741,473
Adjusted EBITDA                 343,706 275,933 259,241
Total Restructuring Initiatives                 3,589    
Depreciation and amortization                 51,495 41,143 39,776
Capital Expenditures                 54,433 33,005 58,970
Total Assets 1,324,696       881,443       1,324,696 881,443 831,569
Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net sales                 383,727 349,617 328,375
Adjusted EBITDA                 57,589 62,903 61,588
Total Restructuring Initiatives                 4,185 1,679  
Depreciation and amortization                 27,467 24,720 23,891
Capital Expenditures                 41,236 38,730 21,533
Total Assets 501,700       296,271       501,700 296,271 259,282
Corporate & Other                      
Financial information regarding the Company's reportable segments                      
Adjusted EBITDA                 (36,285) (37,457) (31,712)
Total Restructuring Initiatives                 3,811    
Depreciation and amortization                 9,239 7,809 6,862
Capital Expenditures                 25,739 18,924 17,490
Transfer of Corporate Technology Expenditures                 (11,527) (10,460) (44,172)
Total Assets $ 177,523       $ 601,826       177,523 601,826 245,076
Operating segment                      
Financial information regarding the Company's reportable segments                      
Net sales                 2,787,989 2,491,444 2,349,855
Operating segment | Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net sales                 1,446,231 1,333,048 1,278,151
Operating segment | Pharma                      
Financial information regarding the Company's reportable segments                      
Net sales                 955,069 805,913 741,473
Operating segment | Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net sales                 386,689 352,483 330,231
Intersegment                      
Financial information regarding the Company's reportable segments                      
Net sales                 (23,228) (22,161) (18,921)
Intersegment | Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net sales                 (19,849) (19,262) (17,065)
Intersegment | Pharma                      
Financial information regarding the Company's reportable segments                      
Net sales                 (417) (33)  
Intersegment | Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net sales                 $ (2,962) $ (2,866) $ (1,856)